#	Pagina
attuale pagina	/open-h2020/projects/216738/index.html

Opendata, web and dolomites

ONCOTICS

Probiotics for the Oncological Patients

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

ONCOTICS project word cloud

Explore the words cloud of the ONCOTICS project. It provides you a very rough idea of what is the project "ONCOTICS" about.

syndrom gut disrupted viability barrier safe time introduces developped favorably cuase technological sepsis perform biologically oncological treatment opening therapy active life infections standard probioticsmodify intestinal probiotics mucosa leaky mucosal oncology economical membrane preserves elemination stabilization oncotics gentle probiotic immune inflammatory bacteria intestines suppress comfort newly molecules microbiome regeneration probiotical integrity designed comercial damaged markets patients mucous patented lysis microbial cells lysates brings form

Project "ONCOTICS" data sheet

The following table provides information about the project.

Coordinator	PHARMACEUTICAL BIOTECHNOLOGY SRO Organization address address: SLEZSKA 949/32 city: PRAHA postcode: 12000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Czech Republic [CZ]
Project website	http://www.pharmabiotech.cz
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2018
Duration (year-month-day)	from 2018-06-01 to 2018-11-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	PHARMACEUTICAL BIOTECHNOLOGY SRO PHARMACEUTICAL BIOTECHNOLOGY SRO Organization address address: SLEZSKA 949/32 city: PRAHA postcode: 12000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CZ (PRAHA)	coordinator	50˙000.00

Map

Project objective

The main objective of this project is to perform the technological/comercial and economical viability of the newly developped very gentle form of microbial lysis which preserves the biologically active molecules of probiotic bacteria that favorably affects the cells of the intestinal mucosa and the mucosal immune system. This newly designed probioticsmodify the integrity of the intestinal mucosa damaged as a result of oncological treatment, to suppress inflammatory changes in the mucous membrane and, at the same time, to contribute to stabilization by the treatment of the disrupted microbiome. The ONCOTICS introduces novel treatment of intestines infections which brings : - Unique probiotical lysates product improving the oncology patients life comfort - New approach for elemination of syndrom leaky gut in oncological patients - Very safe gut barrier regeneration compared with standard probiotics, which can cuase sepsis - New patented technology for production of probiotics lysates - Novel therapy opening new markets

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ONCOTICS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ONCOTICS" are provided by the European Opendata Portal: CORDIS opendata.